Talking about buprenorphine and methadone for opioid use
Part of Mental health clinical trials.
This trial is testing a conversation approach to help people start medication for opioid use disorder (like buprenorphine or methadone). It may be a good fit if you've had an overdose, opioid withdrawal, or other serious problem from opioid use and are not already on these medications.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 16 or older
- You have a condition that suggests you need medication for opioid use disorder (like an opioid overdose, withdrawal, or complications from injecting opioids)
- You are not currently taking buprenorphine or methadone (and have not taken them in the past 7 days)
- You are willing to talk about starting medication for opioid use disorder
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether starting buprenorphine using a low-dose plan is a safe and workable way to treat opioid use disorder. You may be able to join if you are 18+, have opioid use disorder, and can follow the study medication and visits.
This trial studies a program meant to improve treatment access and support recovery for people with opioid use disorder who also have mental health symptoms. It may help if you are new to the program or recently relapsed, or if mental health symptoms have worsened—even without a relapse.
This Phase 3 study tests whether using smartphones can help people with opioid-use disorder stick with treatment and recover more successfully. It focuses on people starting or already in treatment using methadone or buprenorphine, with support delivered through the study app or messages.
This trial tests a long-acting, once-monthly injection of buprenorphine (BRIXADI) given from a mobile pharmacy clinic. It aims to see if this approach is acceptable and practical for people with opioid use disorder, making treatment more accessible.
This trial tests different doses of buprenorphine to find the safest and most effective one for treating opioid use disorder and preventing overdose. It is for people who have used fentanyl and are starting or continuing buprenorphine treatment.
This study compares two medications, methadone and buprenorphine, to see which helps people stay in treatment for opioid use disorder. You may be eligible if you are starting a new treatment episode.
Hear when a new Opioid Use Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.